Hormonal treatment of bilateral proximal tubal obstruction.

article OA: closed CC0
View on OpenAlex View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-08-08

Hormonal suppressive therapy with GnRH agonists, norethindrone acetate, or danazol for at least 3 months opened at least one fallopian tube in 69.6% of infertile patients with bilateral proximal tubal obstruction, leading to conception in 39.1%.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To see whether medical suppressive treatment might be considered in the treatment of a subgroup of patients. with proximal tubal obstruction (PTO), one of the major causes for infertility, often due to endometriosis of the tubouterine junction and therefore primarily treated by operative procedures. METHODS: 23 infertile patients with bilateral PTO were treated with hormonal suppression therapy with GnRH agonists, norethindrone acetate, or danazol for at least 3 months. The average age of the patients and duration of infertility were (mean + SD) 32.4 +/- 4.8 and 3.9 +/- 2.2, respectively. Bilateral PTO was diagnosed by both hysterosalpingography and laparoscopy. RESULTS: Fifteen of the 23 patients (65%) were diagnosed as having pelvic endometriosis prior to treatment. Following the treatment, 16 of the 23 patients (69.6%) were shown to have have at least one patent fallopian tube, and 9 patients conceived (39.1%). No patient became pregnant in the absence of one patent tube after treatment. CONCLUSION: Hormonal suppressive therapy can be an alternative treatment in patients with bilateral PTO for a period as short as 3 months before any invasive procedure.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Danazol Fallopian Tube Diseases Infertility, Female Leuprolide Norethindrone Pregnancy Adult Danazol Drug Administration Schedule Estrogen Antagonists Estrogen Antagonists Evaluation Studies as Topic Fallopian Tube Diseases Fallopian Tube Diseases Fallopian Tube Diseases Female Fertility Agents, Female Fertility Agents, Female Follow-Up Studies Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-16T09:21:09.727480+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:10:24.024533+00:00
License: CC0 · commercial use OK